Posted by Michael Wonder on 11 Nov 2020
Therapeutic Goods Administration gives green light for early Pfizer vaccine
11 November 2020 - The nation’s medicines regulator has paved the way for an early release of Pfizer’s breakthrough COVID-19 vaccine by placing the drug on a priority path to approval, despite human trials not concluding until late this month.
The Therapeutic Goods Administration has already begun assessing the safety of the Pfizer coronavirus vaccine — known as BNT162b2 — by granting it a provisional determination reserved for urgently required drugs.
